Press Releases Nuo Therapeutics, Inc.

Equities

AURX

US67059V2097

Market Closed - OTC Markets Other stock markets 14:51:14 15/05/2024 BST			5-day change	1st Jan Change
0.75 ^USD	0.00%		-6.25%	+36.36%

04-19	Nuo Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
03-19	Exor-backed NUO invests in Italian teenage clothing chain Subdued	RE

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Nuo Therapeutics Selected to Exhibit Aurix® System at Vizient Innovative Technology Exchange	26/06/23	AQ
Nuo Therapeutics’ Aurix® System Added To Wound Care Formulary Of Wound Care Advantage	22/06/23	AQ
NUO THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	17/04/23	AQ
NUO THERAPEUTICS, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)	05/12/22	AQ
NUO THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	04/11/22	AQ
NUO THERAPEUTICS, INC. : Shareholder Director Nominations, Other Events (form 8-K)	30/09/22	AQ
Nuo Therapeutics Provides Corporate and Business Update	30/08/22	AQ
NUO THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	30/08/22	AQ
Nuo Therapeutics : Amendment to Quarterly Report - Form 10-Q/A	10/08/22	PU
NUO THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q/A)	10/08/22	AQ
NUO THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	08/08/22	AQ
NUO THERAPEUTICS, INC. : Other Events (form 8-K)	28/06/22	AQ
NUO THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	16/05/22	AQ
NUO THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	02/05/22	AQ
NUO THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	15/04/22	AQ
Nuo Therapeutics Responds to Mini-Tender Offer	04/02/22	GL
Alternative Liquidity Index Announces Offer to Purchase Shares in Nuo Therapeutics, Inc.	21/01/22	AQ
NUO THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	04/01/22	AQ
NUO THERAPEUTICS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)	21/04/21	AQ
Nuo Therapeutics : Announces Publication of Final Decision Memo for Autologous Blood Derived Products for Chronic Non-Healing Wounds by Centers for Medicare & Medicaid Services	20/04/21	PR

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Nuo Therapeutics, Inc.

Equities

AURX

US67059V2097

Press Releases

Filters